Gamma Delta T Cells and Their Pathogenic Role in Psoriasis

Gamma Delta T Cells and Their Pathogenic Role in Psoriasis

γδT cells are an unconventional population of T lymphocytes that play an indispensable role in host defense, immune surveillance, and homeostasis of the immune system. They display unique developmental, distributional, and functional patterns and rapidly respond to various insults and contribute to...

Full description

Bibliographic Details
Main Authors:	Cong Qi, Yazhuo Wang, Ping Li, Jingxia Zhao
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Immunology
Subjects:	psoriasis γδT IL-17 skin inflammation biological function
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.627139/full

Similar Items

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
by: Stefania Madonna, et al.
Published: (2019-07-01)

The Role of Gamma-Delta T Cells in Diseases of the Central Nervous System
by: Jin Wo, et al.
Published: (2020-10-01)

Hyperforin Ameliorates Imiquimod-Induced Psoriasis-Like Murine Skin Inflammation by Modulating IL-17A–Producing γδ T Cells
by: Song Zhang, et al.
Published: (2021-05-01)

Tuhuaiyin alleviates imiquimod-induced psoriasis via inhibiting the properties of IL-17-producing cells and remodels the gut microbiota
by: Tingting Di, et al.
Published: (2021-09-01)

Prostaglandin E2 amplifies IL-17 production by γδ T cells during barrier inflammation
by: Barbara Polese, et al.
Published: (2021-07-01)

The Jekyll and Hyde story of IL17 producing γδT (Tγδ17) cells
by: Rushikesh Sudam Patil, et al.
Published: (2015-02-01)

Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies
by: Hélène Bugaut, et al.
Published: (2021-02-01)

Clinical utility of ixekizumab in the treatment of moderate-to-severe plaque psoriasis
by: Sekhon S, et al.
Published: (2017-11-01)

REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model
by: Shangyi Wang, et al.
Published: (2021-12-01)

Advances in Understanding the Immunological Pathways in Psoriasis
by: Simona-Roxana Georgescu, et al.
Published: (2019-02-01)

Successful use of Netakimab in the treatment of psoriasis accompanied by the psoriatic onychodystrophy
by: N. N. Potekaev, et al.
Published: (2020-10-01)

Interleukin-17A Drives IL-19 and IL-24 Expression in Skin Stromal Cells Regulating Keratinocyte Proliferation
by: Xiaofei Xu, et al.
Published: (2021-09-01)

Secukinumab in the treatment of psoriasis: patient selection and perspectives
by: Yang EJ, et al.
Published: (2018-10-01)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
by: Giunta A, et al.
Published: (2017-06-01)

Spotlight on brodalumab in the treatment of moderate-to-severe plaque psoriasis: design, development, and potential place in therapy
by: Roman M, et al.
Published: (2017-07-01)

Increased Levels of Interleukin-17A Exosomes in Psoriasis
by: Claire Jacquin-Porretaz, et al.
Published: (2019-09-01)

Emerging targeted therapies for plaque psoriasis – impact of ixekizumab
by: Kazemi T, et al.
Published: (2017-04-01)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
by: Ester Muñoz-Aceituno, et al.
Published: (2020-12-01)

Role of IL-17 in plaque psoriasis: therapeutic potential of ixekizumab
by: Hanley TL, et al.
Published: (2017-03-01)

Biological therapies in psoriasis - revisited
by: Sârbu Maria-Isabela, et al.
Published: (2018-06-01)

Transcription Factor KLF10 Constrains IL-17-Committed Vγ4+ γδ T Cells
by: Girak Kim, et al.
Published: (2018-02-01)

Targeting IL-23: Insights into the pathogenesis and the treatment of psoriasis
by: Lima Hermenio, et al.
Published: (2010-01-01)

Interleukin-17 levels in patients with psoriasis with or without metabolic syndrome
by: Hanan Morsy, et al.
Published: (2019-01-01)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
by: Nicolo Costantino Brembilla, et al.
Published: (2018-08-01)

Use of Anti-IL-17 Monoclonal Antibodies in HIV Patients with Erythrodermic Psoriasis
by: Mary Catherine G. Pangilinan, et al.
Published: (2020-08-01)

From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment
by: Silvia Vidal, et al.
Published: (2021-06-01)

Constitutive RIG-I activation causes skin lesion resembling psoriasis in transgenic mice
by: Ahmed, S.A. Abu Tayeh
Published: (2021)

Bimekizumab: the new drug in the biologics armamentarium for psoriasis
by: Egídio Freitas, et al.
Published: (2021-06-01)

Biologic Treatments of Psoriasis: An Update for the Clinician
by: Brownstone ND, et al.
Published: (2021-02-01)

IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients
by: Yuling Shi, et al.
Published: (2019-08-01)

A highly focused antigen receptor repertoire characterizes γδ T cells that are poised to make IL-17 rapidly in naive animals
by: Yu-Ling eWei, et al.
Published: (2015-03-01)

Upregulation of Intestinal Barrier Function in Mice with DSS-Induced Colitis by a Defined Bacterial Consortium Is Associated with Expansion of IL-17A Producing Gamma Delta T Cells
by: Ming Li, et al.
Published: (2017-07-01)

Highlighting Interleukin-36 Signalling in Plaque Psoriasis and Pustular Psoriasis
by: Kazuhisa Furue, et al.
Published: (2017-10-01)

Impact of Ixekizumab Treatment on Itch and Psoriasis Area and Severity Index in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase III Randomized Studies
by: Gil Yosipovitch, et al.
Published: (2018-11-01)

Imbalance of γδT17/γδTreg cells in the pathogenesis of allergic asthma induced by ovalbumin
by: Xia Yang, et al.
Published: (2018-07-01)

Activation of iNKT Cells Prevents Salmonella-Enterocolitis and Salmonella-Induced Reactive Arthritis by Downregulating IL-17-Producing γδT Cells
by: Mariángeles Noto Llana, et al.
Published: (2017-09-01)

Xiao-Yin-Fang Therapy Alleviates Psoriasis-like Skin Inflammation Through Suppressing γδT17 Cell Polarization
by: Xilin Zhang, et al.
Published: (2021-04-01)

Innate γδT17 cells play a protective role in DSS-induced colitis via recruitment of Gr-1+CD11b+ myeloid suppressor cells
by: Xuan Sun, et al.
Published: (2017-05-01)

Interferon Kappa Is Up-Regulated in Psoriasis and It Up-Regulates Psoriasis-Associated Cytokines in vivo
by: Li Y, et al.
Published: (2019-11-01)

Systems Pharmacology Approach and Experiment Evaluation Reveal Multidimensional Treatment Strategy of LiangXueJieDu Formula for Psoriasis
by: Jingxia Zhao, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_q46uv9i31o77uhsjce5n6hbmu3